Chemical Name: 2-(((3aS,4R,6S,6aR)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol (2S,3S)-2,3-dihydroxysuccinate
Smiles: N[C@H]1C[C@@H](OCCO)[C@@]2([H])[C@]1([H])OC(C)(C)O2.OC([C@@H](O)[C@H](O)C(O)=O)=O
Inchi: InChI=1S/C38H44F2N8O4/c1-3-4-36(27(2)49)48-37(50)47(26-43-48)32-8-6-30(7-9-32)44-15-17-45(18-16-44)31-10-12-33(13-11-31)51-21-28-20-38(52-22-28,23-46-25-41-24-42-46)34-14-5-29(39)19-35(34)40/h5-14,19,24-28,36,49H,3-4,15-18,20-23H2,1-2H3/t27-,28+,36-,38-/m1/s1
Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.
From World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.
Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav
From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724
Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara
From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42